SynthesisPharmacoepidemiology and drug safety2025

Quantitative Benefit-Risk Assessment of Vaccination Against COVID-19: A Systematic Review.

E Claire Newbern et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.